Important safety information Prescribing Information

REGISTRATION

Articles about Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% and other information are made available to health care professionals through this product Web site.

Register below to receive the latest communications from Epiduo® Gel, including clinical studies, treatment information, patient/practice resources, and product offers.

Galderma is committed to protecting and safeguarding your privacy. To better understand how we use the data you provide from this site, please read our Privacy Policy. We will not sell your information, and you will not receive anything from us that you have not agreed to receive.

Title:
* First Name 
* Last Name 
* Address 1 
  Address 2  
* Zip  
* State 
* City 
* Email 
* Password:
* Confirm Password:
* Specialty:

Important Safety Information

Epiduo® Gel is a retinoid and antimicrobial combination product indicated for the topical treatment of acne vulgaris in patients 12 years and older. The most common adverse events associated with use of Epiduo® Gel are erythema, scaling, dryness, stinging and burning. In addition, in clinical trials, adverse events reported in greater than 1% of patients treated with the Gel included contact dermatitis and skin irritation. Excessive exposure to sunlight and sunlamps should be avoided during treatment, and use of sunscreen products and protective clothing is recommended. Concomitant use of irritating topical products (like products containing resorcinol, salicylic acid or sulfur) should be avoided. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see full Prescribing Information.

This site is intended for U.S. healthcare professionals only.
Are you a healthcare professional?
Sign in or register to
access this exclusive
content and to gain
future access to:
Log in for exclusive physician resources.

Email:
Password:
Not registered? Get access now
Forgot your password? Click here